Determinants of adherence in adults with cystic fibrosis

Lisa J Kettler, S M Sawyer, H R Winefield, H W Greville, Lisa J Kettler, S M Sawyer, H R Winefield, H W Greville

Abstract

Cystic fibrosis (CF) is now as much a disease of adults as of children and adolescents. An important focus of recent research has been the impact of the complex, expensive, and time consuming routine of self-care and medical treatment that is required by adults with CF to maintain health. A growing concern for medical and allied health teams is the issue of patient adherence to prescribed health management plans. A summary of the particular medical and treatment context of CF is followed by a review of adherence measurement issues and the determinants of adherence to treatment regimens in people with CF, primarily adults. Evidence for factors which influence adherence decisions of people with CF is examined. The medical and psychological aspects of this complex problem have not been adequately addressed because of difficulties with definition and measurement. Only a small proportion of the variance in adherence has been accounted for in the literature. New measurement technologies and new theoretical directions offer promise for a better understanding of this complex and important issue and may result in more effective intervention strategies to improve adherence.

References

    1. J Dev Behav Pediatr. 1999 Oct;20(5):335-43
    1. J Paediatr Child Health. 1999 Aug;35(4):350-4
    1. Thorax. 2000 Sep;55(9):798-804
    1. Am J Dis Child. 1975 Sep;129(9):1011-3
    1. Health Educ Monogr. 1978 Spring;6(2):107-17
    1. J Consult Clin Psychol. 1982 Dec;50(6):950-71
    1. J Allergy Clin Immunol. 1986 Jan;77(1 Pt 1):65-70
    1. J Child Psychol Psychiatry. 1987 Mar;28(2):311-9
    1. J Dev Behav Pediatr. 1987 Jun;8(3):141-8
    1. J Allergy Clin Immunol. 1988 Jul;82(1):5-10
    1. Pediatrics. 1990 Jun;85(6):1008-14
    1. Chest. 1990 Jun;97(6):1310-6
    1. Soc Sci Med. 1990;31(3):291-303
    1. J Dev Behav Pediatr. 1990 Dec;11(6):353-8
    1. Am Rev Respir Dis. 1992 Dec;146(6):1559-64
    1. Pediatrics. 1993 Feb;91(2):383-9
    1. Thorax. 1994 Feb;49(2):115-20
    1. J R Soc Med. 1994;87 Suppl 21:25-7
    1. Soc Sci Med. 1994 May;38(9):1307-15
    1. Thorax. 1994 Aug;49(8):798-802
    1. Aust Nurs J. 1994 Oct;2(4):38-40
    1. J Pediatr Psychol. 1995 Jun;20(3):291-7
    1. Thorax. 1995 Jul;50(7):794-6
    1. Thorax. 1995 Oct;50(10):1031-2
    1. Geriatrics. 1996 Mar;51(3):28-35
    1. Thorax. 1996 Jan;51(1):29-33
    1. Thorax. 1996 Jan;51(1):34-8
    1. J Pediatr Psychol. 1996 Apr;21(2):209-35
    1. Thorax. 1996 Dec;51(12):1233-8
    1. J Paediatr Child Health. 1997 Apr;33(2):88-90
    1. Pediatr Pulmonol Suppl. 1997;16:260-1
    1. Disabil Rehabil. 1998 Jun-Jul;20(6-7):217-25
    1. Respir Med. 2000 Jan;94(1):2-9

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever